Opus Genetics (IRD) PT Lowered to $9 at RBC Capital
Tweet
Share
E-mailGet Alerts IRD Hot Sheet
Price: $6.35 +46.31%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
RBC Capital analyst Lisa Walter lowered the price target on Opus Genetics (NASDAQ: IRD) to $9.00 (from $10.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Opus Genetics reports early positive data from gene therapy eye trial
- KIOXIA Holdings (285A:JP) PT Raised to JPY131,000 at Nomura/Instinet
- International Container Terminal Services (ICT:PM) (ICTEF) PT Raised to PHP1,210 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
